Current treatment of atypical mycobacteriosis

Expert Opinion on Pharmacotherapy
Jaime Esteban, Alberto Ortiz-Pérez

Abstract

Atypical mycobacteria are a heterogeneous group of organisms that are of increasing importance because of the growing number of infections they cause. This rising rate of infection is due mainly to the increase in the number of susceptible (and especially immunosuppressed) patients. To revise the currently used treatment schemes of the most commonly isolated atypical mycobacteria. Literature review using reference books and PubMed with specific keywords for each mycobacteria. The first important step in the management of atypical mycobacteria is to recognize the true infections caused by these organisms. The treatment required varies according to species. Well-characterized combinations exist for most common isolates, with the use of first-line antituberculous drugs (isoniazid, rifampin, ethambutol), clarithromycin, aminoglycosides and/or quinolones for slowly growing species (Mycobacterium avium complex, Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium ulcerans, Mycobacterium marinum, Mycobacterium lentiflavum, Mycobacterium malmoense) and macrolides, quinolones, amikacin and other antibiotics for rapidly growing mycobacteria (Mycobacterium abscessus, Mycobacterium chelonae, Mycobacterium fortuitum). Surgical therap...Continue Reading

References

Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E Wolinsky
Jan 1, 1992·Clinical Microbiology Reviews·L G Wayne, H A Sramek
Feb 1, 1995·Molecular Biotechnology·S E Douglas
Jul 1, 1993·International Journal of Systematic Bacteriology·W R ButlerF S Vadney
Jun 1, 1993·Antimicrobial Agents and Chemotherapy·S E HoffnerG Källenius
Jul 1, 1996·Antimicrobial Agents and Chemotherapy·R J WallaceE C Böttger
Mar 1, 1997·Journal of the American Academy of Dermatology·M S Driscoll, S K Tyring
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A ZurawskiH M Blumberg
Aug 1, 1997·The Journal of Antimicrobial Chemotherapy·R P Brettle
May 8, 1999·Clinical and Experimental Dermatology·P EscalonillaL Requena
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L BernardC Perronne
Dec 22, 1999·Antimicrobial Agents and Chemotherapy·R Fernández-RoblasF Soriano
Feb 2, 2000·International Journal of Legal Medicine·S FürediM Angyal
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·A AubryE Cambau
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·R J WallaceR W Wilson
Apr 28, 2001·Journal of Clinical Microbiology·S N NiobeJ Maugein
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·J L KleinG L French
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·N LounisJ Grosset
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter PhillipsJulio Montaner
Feb 5, 2002·Journal of Clinical Microbiology·Enrico TortoliLorenzo Mecocci
Aug 17, 2002·The Pediatric Infectious Disease Journal·Froilán CabriaMaria Soledad Jimenez
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Herve DegaJacques Grosset
Oct 5, 2002·Clinical Microbiology Reviews·Barbara A Brown-Elliott, Richard J Wallace
Mar 8, 2003·Journal of Clinical Microbiology·Caroline TaillardGuy Prod'hom
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Laurent MarsollierStewart T Cole
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Barbara A Brown-ElliottRichard J Wallace
May 23, 2003·Antimicrobial Agents and Chemotherapy·Shun-Cheng YangKwen-Tay Luh
Jun 7, 2003·International Journal of Antimicrobial Agents·J C Rodriguez DíazG Royo
Jul 3, 2003·The Journal of Antimicrobial Chemotherapy·Michael H CynamonAnthony E T Yeo
Dec 3, 2003·The Journal of Antimicrobial Chemotherapy·Angeles García-GarcíaRafael Borrás

❮ Previous
Next ❯

Citations

May 25, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ryan R FalseyMichi M Shinohara
May 22, 2013·International Journal of Medical Microbiology : IJMM·Michael HombachErik C Böttger
Jan 17, 2012·The Veterinary Clinics of North America. Exotic Animal Practice·Jennifer Buur, Miguel D Saggese
Aug 15, 2013·Journal of Cardiac Surgery·Shinya UnaiHitoshi Hirose
Feb 19, 2014·The Journal of Dermatology·Mohamed A El-Khalawany
Jul 6, 2015·Dermatologic Clinics·Tania M Gonzalez-Santiago, Lisa A Drage
Apr 24, 2012·Expert Opinion on Pharmacotherapy·Jaime EstebanFernando Alcaide
Jun 12, 2015·ACS Infectious Diseases·Keith D GreenSylvie Garneau-Tsodikova
May 21, 2011·European Annals of Otorhinolaryngology, Head and Neck Diseases·D-Q NguyenS Schmerber
Nov 27, 2014·Frontiers in Oncology·Khalid Ahmed Al-AnaziWaleed Khalid Al-Anazi
Feb 13, 2015·Anais Brasileiros De Dermatologia·Renan LageAdilson da Costa
Jun 15, 2011·Clinical Pediatrics·Shipra SinghFranca M Iorember
Jul 25, 2019·Respiratory Medicine Case Reports·Marcela Doktorova Demmin, Adrian Gillissen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved